Nigeria’s decision to lift the ban on sachet alcohol has sparked a fierce debate, with public health advocates warning of dire consequences for communities, especially children. But here’s where it gets controversial: while the government cites security concerns, critics argue this move prioritizes industry profits over the well-being of the nation’s most vulnerable. Let’s dive into the details.
The Association of Community Pharmacists of Nigeria (ACPN) has slammed the Federal Government’s reversal of the ban on sachet and small-volume alcohol, labeling it a major setback for public health. In a bold statement, ACPN National Chairman, Mr. Ambrose Ezeh, described the policy shift as “a troubling blow to the country’s health regulation efforts.” This comes after the government, on February 11, instructed the National Agency for Food and Drug Administration and Control (NAFDAC) to halt enforcement of the proposed ban, even ordering them to stop sealing factories and warehouses involved in sachet alcohol production. The directive, issued by Terrence Kuanum, Special Adviser on Public Affairs to the Secretary to the Government of the Federation (SGF), was reportedly driven by security concerns arising from continued enforcement.
But is this enough to justify putting public health at risk? Ezeh argues that the original ban was grounded in evidence-based harm-reduction principles and a commitment to protecting children. He highlights that in 2018, NAFDAC, the Ministry of Health and Social Welfare, and the Federal Competition and Consumer Protection Commission (FCCPC) signed a five-year agreement with industry operators to phase out sachet alcohol by January 31, 2024. This deadline was later extended to December 2025 to allow manufacturers time to adjust. Yet, the reversal raises questions about regulatory consistency and the government’s priorities.
And this is the part most people miss: Alcohol misuse is a silent epidemic in Nigeria, contributing to nearly 29% of preventable deaths and almost half of all road traffic accidents. In 2016 alone, over 60,000 deaths were linked to alcohol-related causes, including liver disease, cancers, and fatal crashes. Sachet alcohol, with its affordability and accessibility, is a major driver of this harm, particularly among minors. Studies show that children often prefer sachets and small bottles because they are cheap, easy to carry, and simple to hide. Instead of supporting regulations aimed at harm reduction and child protection, industry players have ramped up lobbying efforts, reframing the debate around affordability and moderate consumption—a move Ezeh calls a distressing abandonment of corporate social responsibility.
Here’s the controversial question: Should Nigeria sacrifice the health and future of its children for short-term economic gains? Ezeh argues that the public health cost-benefit analysis is clear: the long-term social and economic burdens of alcohol misuse far outweigh any temporary industry profits. He emphasizes that the case against sachet alcohol is straightforward—its packaging encourages easy access and concealment by minors. Any policy review, he insists, must prioritize child safety, regulatory integrity, and evidence-based prevention.
But here’s another angle to consider: While warning labels and age restrictions are important, without supply-side controls, compliance efforts may fall flat. Ezeh points out that the reversal reflects broader enforcement weaknesses, such as the failure to eliminate open drug markets that distribute counterfeit and substandard medicines. These inconsistencies erode institutional credibility and public trust in regulatory bodies.
Nigeria now stands at a critical crossroads. When the choice is between safeguarding public health and preserving profit margins, the ethical decision should be clear. But what do you think? Is the government’s reversal a necessary compromise, or a dangerous precedent? Share your thoughts in the comments—this is a conversation that needs your voice.
